Indra Q1 2026 presentation: 15% revenue growth amid analyst miss

Indra reported Q1 2026 revenue of €1.334 billion, up 14.6% year over year but below the roughly $1.59 billion analyst forecast, and shares fell 2.19% pre-market to €49.26. Operating performance was stronger, with EBIT up 24.2% to €118 million, EBITDA up 54.7% to €194 million, and net income up 28.4% to €76 million, while backlog expanded sharply in Defence (+279% to €11.4 billion) and Space (+393% revenue to €89 million). Management reaffirmed full-year 2026 guidance for revenue above €7 billion, EBIT above €700 million, and free cash flow above €375 million excluding PEM advances.

Analysis

The market is penalizing a headline revenue miss, but the more important signal is that Indra is transitioning from a backlog-heavy contractor into a capacity-constrained industrial compounder. The real upside convexity sits in defense and space: once new plants and labor ramp in H2 2026, incremental revenue should carry much higher margin than today’s mix, so the current quarter likely understates forward EBIT power. That said, the backlog conversion story is execution-sensitive; if ramp-up slips even one quarter, investors will keep treating the stock as “order intake rich, cash conversion poor.”

Second-order winners are domestic and European suppliers tied to armored vehicles, radar, satellite subsystems, and electronics bottlenecks, because Indra’s growth implies sustained component demand into 2027. The clearest losers are smaller software-heavy defense contractors and civil-tech peers that lack this level of sovereign spending exposure; they face a funding squeeze as capital and procurement budgets concentrate toward strategic autonomy platforms. A hidden risk is that elevated defense and space capex can strain working capital and supplier terms, especially if governments continue using prepayments as a financing tool.

The biggest misread is the size of the optionality from the space business: the market may be valuing it as a bolt-on, but the backlog and high margin profile make it a re-rating lever if management proves it can cross-sell ground, launch, and downstream services. The near-term downside is less about demand and more about valuation discipline; after a strong run, any sign that organic growth alone is below the stated medium-term path could compress multiples before the backlog converts. Catalysts over the next 1-3 months are guidance-related follow-through, contract awards, and evidence that new facilities are actually moving from capex to billings.

Key Decisions for Investors

• Go long Indra on a 6-12 month horizon on weakness after the post-earnings pullback; risk/reward is attractive if management proves H2 execution, with upside from backlog-to-revenue conversion and margin expansion, but cap position at 1/2 normal size until plant ramp evidence emerges.
• Pair trade: long European defense beneficiaries with backlog visibility / short lower-quality industrial tech names without sovereign exposure; the spread should widen over the next 2-4 quarters as procurement spending concentrates in strategic autonomy programs.
• Buy 3-6 month call spreads on Indra rather than outright stock to express the re-rating thesis with defined downside; use strikes that benefit from a modest multiple expansion rather than requiring flawless execution.
• If space segment bookings continue to accelerate, add on confirmation rather than anticipation; the key catalyst is evidence that the integrated space platform becomes a recurring-margin business, not just an acquisition artifact.
• For risk management, reduce exposure if organic growth decelerates for two consecutive quarters or if working capital turns persistently negative outside seasonality; that would signal backlog quality is less durable than the headline order book suggests.